Arabic Arabic English English French French German German
dark

Oridonin induces apoptosis in human oral cancer cells via phosphorylation of histone H2AX.

PMID: 

Eur J Oral Sci. 2017 12 ;125(6):438-443. Epub 2017 Oct 30. PMID: 29083074

Abstract Title: 

Oridonin induces apoptosis in human oral cancer cells via phosphorylation of histone H2AX.

Abstract: 

Oridonin, a natural diterpenoid purified from Rabdosia rubescens, has displayed beneficial biological activities, including anti-proliferation and anti-angiogenesis effects, in various types of cancers. However, the anti-cancer potential of oridonin and its mechanism in oral cancer have never previously been studied. In this study, we assessed the role of oridonin as an inducer of apoptosis in HSC-3 and HSC-4 human oral cancer cells. Our results showed that oridonin reduces the viability of human oral cancer cells and significantly increases the expression ofγH2AX, a well-known marker of DNA damage. 4′,6-Diamidino-2-phenylindole (DAPI) staining and western blotting showed that oridonin causes nuclear condensation and fragmentation, and induces cleavage of poly(ADP-ribose) polymerase (PARP). Moreover, oridonin-induced γH2AX accumulation was partially abrogated by Z-VAD, a pan-caspase inhibitor. Taken together, our results suggest that oridonin can effectively induce apoptosis by augmenting the expression of γH2AX in response to DNA damage and might be a promising anti-cancer drug candidate for the treatment of oral cancer.

read more

Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Innovatus Imaging is Opening up a Virtual Tour of Its Proprietary Technology Developed Over Nearly 40 Years

Next Post

Anti-leukemia effect and mechanism of oridonin on omatinib-sensitive and imatinib-resistant K562 cells.

Related Posts
Total
0
Share